IFRX (InflaRx NV) Days Inventory: 0.00 (As of Mar. 2026)


IFRX InflaRx NV IFRX
31 GF Score
Price $2.24
! 5 Warning Signs
View Full Analysis

What is InflaRx NV Days Inventory?

InflaRx NV IFRX -3.03% 31 Days Inventory is 0.00 as of Mar. 2026. GuruFocus rates IFRX with a GF Score™ of 31/100. The stock has 5 warning signs investors should review. Among 638 Biotechnology companies, InflaRx NV ranks worse than 66.3% on this metric.

Days Inventory is also known as Days Sales of Inventory (DSI). InflaRx NV's Average Total Inventories for the three months ended in Mar. 2026 was $0.00 Mil. InflaRx NV's Cost of Goods Sold for the three months ended in Mar. 2026 was $0.00 Mil.

The historical rank and industry rank for InflaRx NV's Days Inventory or its related term are showing as below:

IFRX' s Days Inventory Range Over the Past 10 Years
Min: 285.32   Med: 1031   Max: 7801.56
Current: 285.32

During the past 11 years, InflaRx NV's highest Days Inventory was 7801.56. The lowest was 285.32. And the median was 1031.00.

IFRX's Days Inventory is ranked worse than
66.3% of 638 companies
in the Biotechnology industry
Industry Median: 183.875 vs IFRX: 285.32

InflaRx NV's Days Inventory declined from Mar. 2025 (66,963.81) to Mar. 2026 (0.00).

Warning Sign:

If a company builds up inventory, it may mean it is having difficulties selling its goods.

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.


InflaRx NV  (NAS:IFRX) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

InflaRx NV's Inventory Turnover for the three months ended in Mar. 2026 is calculated as

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

InflaRx NV's Inventory to Revenue for the three months ended in Mar. 2026 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.


InflaRx NV Days Inventory Related Terms


InflaRx NV Days Inventory Historical Data

* Premium members only.

The historical data trend for InflaRx NV's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

InflaRx NV Days Inventory Chart

InflaRx NV Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Days Inventory
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 7,801.56 1,031.00 309.84

InflaRx NV Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Days Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 66,963.81 218.73 536,686.88 95.49 0.00

IFRX vs BCYC, ELDN, ZNTL: Days Inventory Comparison

For the Biotechnology subindustry, InflaRx NV's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


InflaRx NV Days Inventory vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, InflaRx NV's Days Inventory distribution charts can be found below:

* The bar in red indicates where InflaRx NV's Days Inventory falls into.


IFRX
31GF Score
InflaRx NV IFRX
Days Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

InflaRx NV Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

InflaRx NV's Days Inventory for the fiscal year that ended in Dec. 2025 is calculated as

Days Inventory (A: Dec. 2025 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (A: Dec. 2024 ) + Total Inventories (A: Dec. 2025 )) / count ) / Cost of Goods Sold (A: Dec. 2025 )*Days in Period
=( (7.223 + 0) / 1 ) / 8.509*365
=7.223 / 8.509*365
=309.84

InflaRx NV's Days Inventory for the quarter that ended in Mar. 2026 is calculated as:

Days Inventory (Q: Mar. 2026 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (Q: Dec. 2025 ) + Total Inventories (Q: Mar. 2026 )) / count ) / Cost of Goods Sold (Q: Mar. 2026 )*Days in Period
=( (0 + 0) / 1 ) / 0*365 / 4
=0 / 0*365 / 4
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Inventory →
What does a Days Inventory of 0.00 mean?
InflaRx NV (IFRX) has a Days Inventory of 0.00 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on InflaRx NV and its competitors. Over the past decade, InflaRx NV's Days Inventory has ranged from 285.32 to 7,801.56. According to the industry distribution chart, InflaRx NV ranks #423 out of 638 companies in the Biotechnology industry, placing it in the top 66.3%.
Is InflaRx NV's Days Inventory too high?
InflaRx NV's current Days Inventory is 0.00. Over the past 10 years, this metric has ranged from a low of 285.32 to a high of 7,801.56. Based on the distribution chart, InflaRx NV ranks #423 out of 638 companies in the Biotechnology industry, which is below the industry midpoint. Overall, InflaRx NV has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does InflaRx NV's Days Inventory compare to BCYC and ELDN?
According to the Biotechnology industry distribution chart, InflaRx NV ranks #423 out of 638 companies for Days Inventory. This places InflaRx NV in the lower half of its industry. The industry median Days Inventory is 183.88. Historically, InflaRx NV's own Days Inventory has ranged from 285.32 to 7,801.56 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.88, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on InflaRx NV and its competitors. For the Biotechnology industry, the median Days Inventory is 183.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. InflaRx NV's current Days Inventory is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is InflaRx NV stock overvalued right now?
InflaRx NV (IFRX) has a current Days Inventory of 0.00. The current Days Inventory is 0.00. InflaRx NV's overall GF Score™ is 31/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For InflaRx NV (IFRX), the current Days Inventory is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

InflaRx NV Business Description

Other Exchanges IF0:Germany
Address Winzerlaer Strasse 2, Jena, DEU, 07745
InflaRx NV is a biopharmaceutical company applying proprietary technologies to discover, develop and commercialize potent and specific inhibitors of the complement activation factor known as C5a and its receptor C5aR. With its therapeutic product candidates, vilobelimab and izicopan, the company targets C5a and its receptor C5aR to selectively inhibit the powerful inflammatory response observed in a wide variety of autoimmune and other inflammatory diseases elicited through C5a/C5aR activation. Its product candidate, GOHIBIC (vilobelimab), is a novel intravenously delivered anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.
31GF Score

Get the complete analysis for IFRX

Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.24
Price